NCT06713876View on ClinicalTrials.gov

Long-term Outcomes of Patients Undergoing ECMO-assisted PCI

Active, not recruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

May 30, 2025

Study Completion Date

July 31, 2025

Conditions
Complex High-risk and Indicated Patients
Interventions
DEVICE

VA-ECMO-assisted PCI

A total of 220 consecutive patients with VA-ECMO-assisted PCI will be enrolled. Data related to medical history, procedural characteristics, and outcomes were collected. Clinical follow-up will be conducted in the periprocedural and postoperative at 1 month, 1 year, 2 years, 3 years, 4 years, and 5 years.

Trial Locations (1)

710032

Xijing Hospital, Xi'an

All Listed Sponsors
lead

Ling Tao, MD, PhD

OTHER

NCT06713876 - Long-term Outcomes of Patients Undergoing ECMO-assisted PCI | Biotech Hunter | Biotech Hunter